Rhumbline Advisers Organogenesis Holdings Inc. Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025

A detailed history of Rhumbline Advisers transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 105,212 shares of ORGO stock, worth $476,610. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,212
Previous 112,385 6.38%
Holding current value
$476,610
Previous $485,000 20.62%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$2.66 - $5.34 $19,080 - $38,303
-7,173 Reduced 6.38%
105,212 $385,000
Q1 2025

Apr 08, 2025
SELL
$2.89 - $6.21 $8,326 - $17,891
-2,881 Reduced 2.5%
112,385 $505,000
Q4 2024

May 29, 2025
BUY
$2.77 - $4.43 $7,980 - $12,762
2,881 Added 2.56%
115,266 $368,000
Q4 2024

Jan 30, 2025
BUY
$2.77 - $4.43 $21,110 - $33,761
7,621 Added 7.08%
115,266 $368,000
Q3 2024

Nov 12, 2024
SELL
$2.42 - $3.24 $12,988 - $17,389
-5,367 Reduced 4.75%
107,645 $307,000
Q2 2024

Aug 01, 2024
BUY
$2.28 - $3.03 $7,834 - $10,411
3,436 Added 3.14%
113,012 $316,000
Q1 2024

May 09, 2024
BUY
$2.61 - $4.49 $8,224 - $14,147
3,151 Added 2.96%
109,576 $311,000
Q4 2023

Feb 08, 2024
SELL
$1.97 - $4.21 $2,029 - $4,336
-1,030 Reduced 0.96%
106,425 $435,000
Q3 2023

Nov 09, 2023
BUY
$2.34 - $4.43 $6,647 - $12,585
2,841 Added 2.72%
107,455 $341,000
Q2 2023

Aug 08, 2023
BUY
$1.9 - $4.3 $30,229 - $68,413
15,910 Added 17.94%
104,614 $347,000
Q1 2023

May 11, 2023
SELL
$1.89 - $2.93 $230,736 - $357,703
-122,083 Reduced 57.92%
88,704 $189,000
Q4 2022

Feb 14, 2023
BUY
$2.48 - $3.43 $39,925 - $55,219
16,099 Added 8.27%
210,787 $567,000
Q3 2022

Nov 10, 2022
BUY
$3.14 - $6.43 $52,764 - $108,049
16,804 Added 9.45%
194,688 $631,000
Q2 2022

Aug 11, 2022
BUY
$4.74 - $8.15 $94,008 - $161,638
19,833 Added 12.55%
177,884 $868,000
Q1 2022

May 12, 2022
BUY
$6.47 - $9.57 $253,675 - $375,220
39,208 Added 32.99%
158,051 $1.2 Million
Q4 2021

Feb 10, 2022
BUY
$9.02 - $13.5 $31,398 - $46,993
3,481 Added 3.02%
118,843 $1.1 Million
Q3 2021

Nov 12, 2021
SELL
$13.71 - $17.18 $31,190 - $39,084
-2,275 Reduced 1.93%
115,362 $1.64 Million
Q2 2021

Aug 05, 2021
BUY
$14.92 - $23.23 $1.49 Million - $2.32 Million
99,993 Added 566.73%
117,637 $1.96 Million
Q1 2021

May 06, 2021
BUY
$7.33 - $21.06 $26,065 - $74,889
3,556 Added 25.24%
17,644 $321,000
Q4 2020

Feb 10, 2021
BUY
$3.63 - $7.53 $6,388 - $13,252
1,760 Added 14.28%
14,088 $106,000
Q3 2020

Nov 12, 2020
SELL
$3.29 - $4.58 $11,498 - $16,007
-3,495 Reduced 22.09%
12,328 $47,000
Q2 2020

Aug 13, 2020
BUY
$2.86 - $4.61 $45,253 - $72,944
15,823 New
15,823 $61,000

Others Institutions Holding ORGO

# of Institutions
123
Shares Held
71.9M
Call Options Held
15.1K
Put Options Held
25
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $593M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email